每经记者｜林姿辰 甄素静 每经编辑｜程鹏 廖丹 12月31日，由国家医保局牵头开展的长达3个多月的"回流药"严打战接近尾声。 过去一年，"国家医保局"微信公众号里，与"回流药"有关的文章超过50篇。"开展倒卖医保回流药问题全面治理"，在国家医保局开展医保基金管理突出问 题专项整治"百日行动"中处于首位，足见这一问题得到的重视。 近日，《每日经济新闻》记者采访药店人士、医药流通领域专家发现，大多数药店老板开始对回流药避之不及，市场上的回流药越来越少。记者同时也注 意到，在不断升级的监控体系下，医保套现中介仍在"见缝插针"，网上投诉回流药的帖子仍在更新。为何还有漏网之鱼？消费者网购买到回流药该如何维 权？ 多部门整治倒卖回流药乱象 药店老板开始害怕了 今年1月，《每日经济新闻》刊发《慢性病患者网购的处方药涉嫌多次销售 专家：电商平台是"回流药"重灾区》，揭秘药贩子通过唆使患者以医保价格多 开药、回收多余药品，再经小药店、诊所、民营医院或网络平台销售，形成长期利益链条。 今年以来，国家医保局打击倒卖回流药的手段越发严厉，大多数药店老板对回流药避之不及。据在深圳经营多家药店的黄先生观察，今年以来，无论是线 下实体店还 ...

Core Viewpoint - The article emphasizes the importance of combating the illegal trade of "recycled drugs" to ensure public health and safety, highlighting the government's commitment to innovative regulatory measures to trace drug origins and prevent fraud [1][2]. Group 1: Regulatory Measures - The National Medical Insurance Administration has launched a special action to combat the illegal sale of recycled drugs, showcasing the effectiveness of "code-based supervision" [1]. - Starting from July 1, all medical insurance designated institutions are required to scan the unique "electronic ID" traceability code of each drug box, allowing for traceable drug origins and destinations [1]. Group 2: Risks of Recycled Drugs - Recycled drugs are often sourced through illegal channels, repackaged, or have their information altered, posing significant health risks to patients and disrupting market order [1]. - The methods used by drug traffickers include enticing insured individuals to sell insurance-covered drugs for profit, falsifying documents to disguise the origins of drugs, and neglecting proper storage conditions during the repackaging process [1]. Group 3: Collaborative Efforts - It is essential for pharmaceutical companies, medical institutions, and retail pharmacies to strictly manage drug sales and prevent drugs from entering informal channels [2]. - Public awareness and responsibility are crucial in preventing participation in the illegal trade of insurance-covered drugs, emphasizing that drug safety is a collective responsibility [2].

Core Viewpoint - The article emphasizes the importance of combating the illegal trade of "recycled drugs" to ensure public health and safety, highlighting the government's commitment to innovative regulatory measures to trace and monitor drug sales [2][3]. Group 1: Definition and Risks of Recycled Drugs - Recycled drugs refer to pharmaceuticals that are illegally collected, repackaged, or have their information altered before being resold, often lacking proper regulatory oversight [2]. - These drugs pose significant health risks to patients and disrupt market order, as they are often sourced from dubious channels [2]. Group 2: Regulatory Measures - Starting from July 1, all medical insurance designated institutions are required to scan the unique "electronic ID" traceability code on each box of drugs sold, enhancing the ability to track drug origins and movements [2]. - This initiative aims to expose and eliminate the illegal practices associated with recycled drugs and related insurance fraud [2]. Group 3: Collaborative Efforts Required - A comprehensive approach is necessary to eradicate the illegal drug trade, involving strict management of drug sales by pharmaceutical companies, medical institutions, and retail pharmacies [3]. - Public awareness and responsibility are crucial, as individuals must refrain from participating in the illegal sale of medical insurance drugs [3].